201 related articles for article (PubMed ID: 23228962)
21. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
Li Q; Wu X; Guo L; Shi J; Li J
FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
[TBL] [Abstract][Full Text] [Related]
22. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
Zhang ZY; Fu SL; Xu SQ; Zhou X; Liu XS; Xu YJ; Zhao JP; Wei S
Oncotarget; 2015 Jan; 6(3):1462-77. PubMed ID: 25596743
[TBL] [Abstract][Full Text] [Related]
23. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
24. microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14.
Sun J; Feng X; Gao S; Xiao Z
Mol Med Rep; 2015 Feb; 11(2):1400-6. PubMed ID: 25374067
[TBL] [Abstract][Full Text] [Related]
25. MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.
Yan C; Zhang W; Shi X; Zheng J; Jin X; Huo J
Environ Sci Pollut Res Int; 2018 Jul; 25(19):18385-18391. PubMed ID: 29372517
[TBL] [Abstract][Full Text] [Related]
26. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
27. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
28. PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
Naidu S; Shi L; Magee P; Middleton JD; Laganá A; Sahoo S; Leong HS; Galvin M; Frese K; Dive C; Guzzardo V; Fassan M; Garofalo M
Sci Rep; 2017 Nov; 7(1):15441. PubMed ID: 29133857
[TBL] [Abstract][Full Text] [Related]
29. RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer.
Fukatsu A; Ishiguro F; Tanaka I; Kudo T; Nakagawa K; Shinjo K; Kondo Y; Fujii M; Hasegawa Y; Tomizawa K; Mitsudomi T; Osada H; Hata Y; Sekido Y
Lung Cancer; 2014 Jan; 83(1):23-9. PubMed ID: 24246507
[TBL] [Abstract][Full Text] [Related]
30. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
31. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.
Zhu K; Ding H; Wang W; Liao Z; Fu Z; Hong Y; Zhou Y; Zhang CY; Chen X
Oncotarget; 2016 May; 7(19):28075-85. PubMed ID: 27057632
[TBL] [Abstract][Full Text] [Related]
32. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
34. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ
Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706
[TBL] [Abstract][Full Text] [Related]
35. MiR-122-5p regulates the mevalonate pathway by targeting p53 in non-small cell lung cancer.
Zheng YK; Zhou ZS; Wang GZ; Tu JY; Cheng HB; Ma SZ; Ke C; Wang Y; Jian QP; Shu YH; Wu XW
Cell Death Dis; 2023 Apr; 14(4):234. PubMed ID: 37005437
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis.
Okudela K; Suzuki T; Umeda S; Tateishi Y; Mitsui H; Miyagi Y; Ohashi K
Oncol Rep; 2014 Oct; 32(4):1374-84. PubMed ID: 25050641
[TBL] [Abstract][Full Text] [Related]
38. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.
Liang H; Zhang J; Shao C; Zhao L; Xu W; Sutherland LC; Wang K
J Exp Clin Cancer Res; 2012 Apr; 31(1):36. PubMed ID: 22537942
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S
Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
